Literature DB >> 31095702

Challenges in IBD Research: Environmental Triggers.

Shuk-Mei Ho1, James D Lewis2, Emeran A Mayer3, Scott E Plevy4, Emil Chuang5, Stephen M Rappaport6, Kenneth Croitoru7, Joshua R Korzenik8, Jeffrey Krischer9, Jeffrey S Hyams10, Richard Judson11, Manolis Kellis12, Michael Jerrett2, Gary W Miller13, Melanie L Grant14, Nataly Shtraizent15, Gerard Honig15, Andrés Hurtado-Lorenzo15, Gary D Wu2.   

Abstract

Environmental triggers is part of five focus areas of the Challenges in IBD research document, which also includes preclinical human IBD mechanisms, novel technologies, precision medicine and pragmatic clinical research. The Challenges in IBD research document provides a comprehensive overview of current gaps in inflammatory bowel diseases (IBD) research and delivers actionable approaches to address them. It is the result of a multidisciplinary input from scientists, clinicians, patients, and funders, and represents a valuable resource for patient centric research prioritization. In particular, the environmental triggers section is focused on the main research gaps in elucidating causality of environmental factors in IBD. Research gaps were identified in: 1) epidemiology of exposures; 2) identification of signatures of biological response to exposures; and 3) mechanisms of how environmental exposures drive IBD. To address these gaps, the implementation of longitudinal prospective studies to determine disease evolution and identify sub-clinical changes in response to exposures is proposed. This can help define critical windows of vulnerability and risk prediction. In addition, systems biology analysis and in silico modeling were proposed as approaches to integrate the IBD exposome for the identification of biological signatures of response to exposures, and to develop prediction models of the effects of environmental factors in driving disease activity and response to therapy. This research could lead to identification of biomarkers of exposures and new modalities for therapeutic intervention. Finally, hypothesis-driven mechanistic studies to understand gene-environment interactions and to validate causality of priority factors should be performed to determine how environment influences clinical outcomes.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; antibiotic; diet; environment; epidemiology; exposome; in silico modeling; pollutant; smoking; ulcerative colitis; virus

Mesh:

Year:  2019        PMID: 31095702      PMCID: PMC6787673          DOI: 10.1093/ibd/izz076

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  78 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

2.  ToxCast Chemical Landscape: Paving the Road to 21st Century Toxicology.

Authors:  Ann M Richard; Richard S Judson; Keith A Houck; Christopher M Grulke; Patra Volarath; Inthirany Thillainadarajah; Chihae Yang; James Rathman; Matthew T Martin; John F Wambaugh; Thomas B Knudsen; Jayaram Kancherla; Kamel Mansouri; Grace Patlewicz; Antony J Williams; Stephen B Little; Kevin M Crofton; Russell S Thomas
Journal:  Chem Res Toxicol       Date:  2016-07-20       Impact factor: 3.739

Review 3.  Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease.

Authors:  Miranda C E Lomer; Richard P H Thompson; Jonathan J Powell
Journal:  Proc Nutr Soc       Date:  2002-02       Impact factor: 6.297

4.  Effect of cesium radioisotope on humoral immune status in Ukrainian children with clinical symptoms of irritable bowel syndrome related to Chernobyl disaster.

Authors:  M R Sheikh Sajjadieh; L V Kuznetsova; V B Bojenko
Journal:  Toxicol Ind Health       Date:  2010-09-08       Impact factor: 2.273

Review 5.  Role of environmental pollution in irritable bowel syndrome.

Authors:  Mateusz Marynowski; Aleksandra Likońska; Hubert Zatorski; Jakub Fichna
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

6.  Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis.

Authors:  R S Choung; F Princen; T P Stockfisch; J Torres; A C Maue; C K Porter; F Leon; B De Vroey; S Singh; M S Riddle; J A Murray; J F Colombel
Journal:  Aliment Pharmacol Ther       Date:  2016-04-27       Impact factor: 8.171

7.  The human early-life exposome (HELIX): project rationale and design.

Authors:  Martine Vrijheid; Rémy Slama; Oliver Robinson; Leda Chatzi; Muireann Coen; Peter van den Hazel; Cathrine Thomsen; John Wright; Toby J Athersuch; Narcis Avellana; Xavier Basagaña; Celine Brochot; Luca Bucchini; Mariona Bustamante; Angel Carracedo; Maribel Casas; Xavier Estivill; Lesley Fairley; Diana van Gent; Juan R Gonzalez; Berit Granum; Regina Gražulevičienė; Kristine B Gutzkow; Jordi Julvez; Hector C Keun; Manolis Kogevinas; Rosemary R C McEachan; Helle Margrete Meltzer; Eduard Sabidó; Per E Schwarze; Valérie Siroux; Jordi Sunyer; Elizabeth J Want; Florence Zeman; Mark J Nieuwenhuijsen
Journal:  Environ Health Perspect       Date:  2014-03-07       Impact factor: 9.031

8.  An enteric virus can replace the beneficial function of commensal bacteria.

Authors:  Elisabeth Kernbauer; Yi Ding; Ken Cadwell
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

9.  Integrating ion mobility spectrometry into mass spectrometry-based exposome measurements: what can it add and how far can it go?

Authors:  Thomas O Metz; Erin S Baker; Emma L Schymanski; Ryan S Renslow; Dennis G Thomas; Tim J Causon; Ian K Webb; Stephan Hann; Richard D Smith; Justin G Teeguarden
Journal:  Bioanalysis       Date:  2017-01       Impact factor: 2.681

10.  Non-specific abdominal pain and air pollution: a novel association.

Authors:  Gilaad G Kaplan; Mieczyslaw Szyszkowicz; Jakub Fichna; Brian H Rowe; Eugeniusz Porada; Renaud Vincent; Karen Madsen; Subrata Ghosh; Martin Storr
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more
  21 in total

1.  Impact of Obesity on the Management of Inflammatory Bowel Disease.

Authors:  Amanda M Johnson; Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-07

Review 2.  Challenges in IBD Research: Novel Technologies.

Authors:  Manish Dhyani; Nitin Joshi; Willem A Bemelman; Michael S Gee; Vijay Yajnik; André D'Hoore; Giovanni Traverso; Mark Donowitz; Gustavo Mostoslavsky; Timothy K Lu; Neil Lineberry; Heiko G Niessen; Dan Peer; Jonathan Braun; Conor P Delaney; Marla C Dubinsky; Ashley N Guillory; Maria Pereira; Nataly Shtraizent; Gerard Honig; David Brent Polk; Andrés Hurtado-Lorenzo; Jeffrey M Karp; Fabrizio Michelassi
Journal:  Inflamm Bowel Dis       Date:  2019-05-16       Impact factor: 5.325

Review 3.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

4.  Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases.

Authors:  Gerard Honig; Caren Heller; Andrés Hurtado-Lorenzo
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

Review 5.  The promise of human organoids in the digestive system.

Authors:  Masaaki Funata; Yasunori Nio; Derek M Erion; Wendy L Thompson; Takanori Takebe
Journal:  Cell Death Differ       Date:  2020-11-17       Impact factor: 12.067

Review 6.  Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.

Authors:  Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski
Journal:  Biomolecules       Date:  2019-11-26

Review 7.  Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review.

Authors:  Maria Elaine Araruna; Catarina Serafim; Edvaldo Alves Júnior; Clelia Hiruma-Lima; Margareth Diniz; Leônia Batista
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

8.  Perfluorooctanesulfonic acid modulates barrier function and systemic T-cell homeostasis during intestinal inflammation.

Authors:  Oscar E Diaz; Chiara Sorini; Rodrigo A Morales; Xinxin Luo; Annika Frede; Annette M Krais; Myra N Chávez; Emma Wincent; Srustidhar Das; Eduardo J Villablanca
Journal:  Dis Model Mech       Date:  2021-12-23       Impact factor: 5.758

Review 9.  A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Qingdong Guan
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

10.  Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.

Authors:  Kathy Vagianos; Leigh Anne Shafer; Kelcie Witges; Laura E Targownik; Clove Haviva; Lesley A Graff; Kathryn A Sexton; Lisa M Lix; Michael Sargent; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2021-01-19       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.